Develops mass spectrometry-based imaging and proteomics technologies, including integration of tissue expansion microscopy with mass spectrometry imaging to achieve higher spatial resolution molecular maps of tissues such as tumors and brain.

Murray develops mid-infrared photonic sources and detectors and combines mid-IR spectroscopy with mass-spectrometry imaging to provide complementary optical and biochemical maps of tissue for biomedical sensing.